Curtis Ulleseit v. Bayer Corp.
United States Court of Appeals for the Ninth CircuitDecember 29, 202119-15778California1,551 words
Opinion
Opinion
NOT FOR PUBLICATION FILED
UNITED STATES COURT OF APPEALS DEC 29 2021
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
CURTIS ULLESEIT; LISA WEHLMANN, No. 19-15778
Plaintiffs-Appellees, D.C. No. 3:17-cv-07026-JD
v.
MEMORANDUM*
BAYER HEALTHCARE
PHARMACEUTICALS INC.; et al.,
Defendants-Appellants,
and
BAYER PHARMA AG, FKA Bayer Schering Pharma AG; et al.,
Defendants.
BETH WINKLER, No. 19-15782
Plaintiff-Appellee, D.C. No. 3:18-cv-03077-JD
v.
BAYER HEALTHCARE
PHARMACEUTICALS INC.; et al.,
Defendants-Appellants,
* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. Page 2 of
and
MCKESSON CORPORATION;
MCKESSON MEDICAL-SURGICAL INC.,
Defendants.
On Remand From the United States Supreme Court
Argued and Submitted December 8, 2021 San Francisco, California
Before: WATFORD, FRIEDLAND, and MILLER, Circuit Judges. Dissent by Judge MILLER
Bayer HealthCare Pharmaceuticals Inc., Bayer Corporation, and Bayer
Healthcare LLC (collectively, Bayer) appeal from…